Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: A prospective study

Journal of the American College of Cardiology

Volumn 41, Issue 2, 2003, Pages 231-238

  Yamada, Takahisa ^a   Shimonagata, Tsuyoshi ^a   Fukunami, Masatake ^a   Kumagai, Kazuaki ^a   Ogita, Hisakazu ^b   Hirata, Akio ^a   Asai, Mitsutoshi ^a   Makino, Nobuhiko ^a   Kioka, Hidetaka ^a   Kusuoka, Hideo ^c   Hori, Masatsugu ^b   Hoki, Noritake ^a  

^a OSAKA GENERAL MEDICAL CENTER   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OSAKA NATIONAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE VARIABILITY; HIGH RISK POPULATION; HOLTER MONITORING; HOSPITALIZATION; HUMAN; MALE; MATHEMATICAL COMPUTING; MULTIVARIATE ANALYSIS; OUTPATIENT; PARAMETER; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY;

3-IODOBENZYLGUANIDINE; ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; VENTRICULAR FUNCTION, LEFT;

EID: 0037439014     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)02700-6     Document Type: Article

References (32)

1. Floras JS. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J Am Coll Cardiol 1993;22 Suppl A:72-84A.
2. Cohn JN, Levine BT, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic heart failure N Engl J Med 1984;311:819-23.
3. Packer M. The neurohumoral hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992;20:248 -54.
4. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standard of measurement, physiological interpretation, and clinical use. Circulation 1996;93:1043-65.
5. Brouwer J, Van Veldhuisen DJ, Man in'T Veld AJ, et al. Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure. J Am Coll Cardiol 1996;28:1183-9.
6. Ponikowski P, Anker SD, Chua TP, et al. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic cardiomyopathy. Am J Cardiol 1997;79:1645-50.
7. Nolan J, Batin PD, Andrews R, et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom Heart Failure Evaluation Assessment of Risk trial. Circulation 1998;98:1510-6.
8. Fauchier L, Babuty D, Cosnay P, et al. Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1999;33:1203-7.
9. Bonaduce D, Petretta M, Marciano F, et al. Independent and incremental prognostic value of heart rate variability in patients with chronic heart failure. Am Heart J 1999;138:273-84.
10. Wieland DM, Brown LE, Rogers WL, et al. Myocardial imaging with a radioiodinated norepinephrine storage analogue. J Nucl Med 1981;22:22-31.
11. Henderson ES, Kahn JK, Corbett JR, et al. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 1988;78:1192-9.
12. Merlet P, Valette H, Dubois-Rande J-L, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992;33:471-7.
13. Cohen-Solal A, Esanu Y, Logeart D, et al. Cardiac metaiodobenzlguanidine uptake in patients with moderate heart failure: relationship with peak oxygen uptake and prognosis. J Am Coll Cardiol 1999;33:759-66.
14. Imamura Y, Fukuyama T, Mochizuki T, et al. Prognostic value of I-123 metaiodobenzylguanidine imaging and cardiac natriuretic peptide levels in patients with left ventricular dysfunction resulting from cardiomyopathy. Jpn Circ J 2001;65:155-60.
15. Ogita H, Shimonagata T, Fukunami M, et al. Prognostic significance of cardiac I-123 metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study. Heart 2001;86:656-60.
16. Somsen GA, Szabo BM, Van Veldhuisen DJ, de Milliano PAR, de Groot CA, Lie KI. Comparison between iodine-123 metaiodobenzylguanidine scintigraphy and heart rare variability for the assessment of cardiac sympathetic activity in mild to moderate heart failure. Am Heart J 1997;134:456-8.
17. Kurata C, Shouda S, Mikami T, et al. Metaiodobenzylguanidine and heart rate variability in heart failure. Jpn Circ J 1998;62:770-2.
18. Lotze U, Kober A, Kaepplinger S, Neubauer S, Gottschild D, Figulla HR. Cardiac sympathetic activity as measured by myocardial 123-I-metaiodobenzylguanidine uptake and heart rate variability in idiopathic dilated cardiomyopathy. Am J Cardiol 1999;83:1548-51.
19. Goris ML, McKillop JH, Brijandet PA. A fully automated determination of the left ventricular region of interest in nuclear angiography. Cardiovasc Intervent Radiol 1981;4:117-23.
20. Ohtomo N, Terachi S, Tanaka Y, Tokiwano K, Kaneko N. New method of time series analysis and its application to Wolf's sunspot number data. Jpn J Appl Physiol 1994;33:2821-31.
21. Sahn DJ, Demaria A, Kissio J, et al Recommendations regarding quantification in M-mode echocardiography: result of a survey of echocardiographic measurements. Circulation 1978;58:1072-83.
22. Foti A, Kimura S, DeQuattro V, et al. Liquid-chromatographic measurement of catecholamines and metabolites in plasma and urine. Clin Chem 1987;33:2209-13.
23. Hasking GJ, Esler MD, Jennings GL, Burton DB, Johns JA, Korner PI. Norepinephrine spillover to plasma in congestive heart failure: evidence of increased cardiorenal and total sympathetic nerve activity. Circulation 1986;73:615-21.
24. Shofer J, Spielmann R, Schuchert A, Weber K, Schluter M. Iodine-123 metaiodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nerve system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1988;12:1252-8.
25. Imamura Y, Ando H, Mitsuoka W, et al. Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause. J Am Coll Cardiol 1995;26:1594-9.
26. Agostini D, Belin A, Amar MH, et al. Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a I-123 MIBG scintigraphic study. J Nucl Med 2000;41:845-51.
27. Fujimura M, Yasumura Y, Ishida Y, et al. Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy. J Cardiac Fail 2000;6:3-10.
28. Bigger JT, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart rate variability and mortality after myocardial infarction. Circulation 1992;85:164-71.
29. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991;84:482-92.
30. Pard G, Saul JP, Di Rieuzo M, Mancia G. Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation: a critical appraisal. Hypertension 1995;25:1276-86.
31. Ponikowski P, Chua TP, Amadi AA, et al. Detection and significance of a discrete very low frequency rhythm in RR interval variability in chronic congestive heart failure. Am J Cardiol 1996;77:1320-6.
32. Morata A, Sleight P, Pinna GD, et al. Abnormal awake respiratory patterns are common in chronic heart failure and may prevent evaluation of autonomic tone by measures of heart rare variability. Circulation 1997;96:246-52.